A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone
NCT01851707
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
322
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
IPI-145
DRUG:
Placebo
Sponsor
SecuraBio